Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Akebia Therapeutics Inc (NASDAQ:AKBA)

9.52
Delayed Data
As of 11:14am ET
 +0.1239 / +1.32%
Today’s Change
7.27
Today|||52-Week Range
26.77
-18.18%
Year-to-Date
No recent news for Akebia Therapeutics Inc.

Today’s Trading

Previous close9.40
Today’s open9.41
Day’s range8.97 - 9.58
Volume58,788
Average volume (3 months)382,393
Market cap$271.1M
Dividend yield--
Data as of 11:14am ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-513.74%
Earnings growth (this year)+74.88%
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.84

Competitors

 Today’s
change
Today’s
% change
EGLTEgalet Corp+0.25+2.21%
GALEGalena Biopharma Inc-0.01-0.60%
FLKSFlex Pharma Inc+0.70+4.74%
SNTASynta Pharmaceutical...+0.06+3.10%
Data as of 11:31am ET, 07/31/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$0.00
Annual profit (last year)-$37.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John P. Butler
CFO, Treasurer, SVP &
Head-Investor Relations
Jason A. Amello
Corporate headquarters
Cambridge, Massachusetts

Forecasts